Found: 106
Select item for more details and to access through your institution.
Rituximab-induced long-term remission of membranous lupus nephritis.
- Published in:
- Nephrology Dialysis Transplantation, 2006, v. 21, n. 6, p. 1742, doi. 10.1093/ndt/gfk068
- By:
- Publication type:
- Article
Cost-effectiveness of real-world infliximab use in patients with rheumatoid arthritis in Sweden.
- Published in:
- International Journal of Technology Assessment in Health Care, 2010, v. 26, n. 1, p. 54, doi. 10.1017/S0266462309990596
- By:
- Publication type:
- Article
Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.899372
- By:
- Publication type:
- Article
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis.
- Published in:
- Rheumatology, 2016, v. 55, n. 6, p. 1031, doi. 10.1093/rheumatology/kev442
- By:
- Publication type:
- Article
Does disease activity at start of biologic therapy influence work-loss in RA patients?
- Published in:
- Rheumatology, 2016, v. 55, n. 4, p. 729, doi. 10.1093/rheumatology/kev407
- By:
- Publication type:
- Article
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis.
- Published in:
- Rheumatology, 2016, v. 55, n. 2, p. 230, doi. 10.1093/rheumatology/kev297
- By:
- Publication type:
- Article
Does disease activity at the start of biologic therapy influence health care costs in patients with RA?
- Published in:
- Rheumatology, 2015, v. 54, n. 8, p. 1472, doi. 10.1093/rheumatology/kev021
- By:
- Publication type:
- Article
Long-term follow-up in lupus nephritis patients treated with rituximab—clinical and histopathological response.
- Published in:
- Rheumatology, 2013, v. 52, n. 5, p. 847, doi. 10.1093/rheumatology/kes348
- By:
- Publication type:
- Article
Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study.
- Published in:
- Rheumatology, 2012, v. 51, n. 12, p. 2204, doi. 10.1093/rheumatology/kes150
- By:
- Publication type:
- Article
Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial.
- Published in:
- Rheumatology, 2012, v. 51, n. 9, p. 1628, doi. 10.1093/rheumatology/kes082
- By:
- Publication type:
- Article
Ten years with biologics: to whom do data on effectiveness and safety apply?
- Published in:
- Rheumatology, 2011, v. 50, n. 1, p. 204, doi. 10.1093/rheumatology/keq326
- By:
- Publication type:
- Article
Patient-reported 28 swollen and tender joint counts accurately represent RA disease activity and can be used to assess therapy responses at the group level.
- Published in:
- Rheumatology, 2010, v. 49, n. 11, p. 2098, doi. 10.1093/rheumatology/keq197
- By:
- Publication type:
- Article
Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts.
- Published in:
- Rheumatology, 2010, v. 49, n. 8, p. 1502, doi. 10.1093/rheumatology/keq055
- By:
- Publication type:
- Article
LONGTERM SAFETY OF PATIENTS RECEIVING RITUXIMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS.
- Published in:
- Romanian Journal of Rheumatology / Revista Romana de Reumatologie, 2010, v. 19, n. 1, p. 20
- By:
- Publication type:
- Article
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study.
- Published in:
- Modern Rheumatology, 2021, v. 31, n. 3, p. 534, doi. 10.1080/14397595.2020.1847776
- By:
- Publication type:
- Article
Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: a post hoc analysis of the TULIP-1 and TULIP-2 trials.
- Published in:
- Rheumatology, 2023, v. 62, n. 4, p. 1526, doi. 10.1093/rheumatology/keac491
- By:
- Publication type:
- Article
ultrasound negative for subclinical synovitis in arthralgia patients: is it helpful in identifying those not developing arthritis? A longitudinal study in four arthralgia cohorts.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4892, doi. 10.1093/rheumatology/keac239
- By:
- Publication type:
- Article
Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4752, doi. 10.1093/rheumatology/keac185
- By:
- Publication type:
- Article
Blood PD-1+TFh and CTLA-4+CD4+ T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis.
- Published in:
- Rheumatology, 2022, v. 61, n. 3, p. 1233, doi. 10.1093/rheumatology/keab454
- By:
- Publication type:
- Article
A neutrophil signature is strongly associated with increased cardiovascular risk in gout.
- Published in:
- Rheumatology, 2021, v. 60, n. 6, p. 2783, doi. 10.1093/rheumatology/keaa712
- By:
- Publication type:
- Article
Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquine.
- Published in:
- Rheumatology, 2021, v. 60, n. 5, p. 2217, doi. 10.1093/rheumatology/keaa553
- By:
- Publication type:
- Article
Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls.
- Published in:
- Rheumatology, 2021, v. 60, n. 1, p. 207, doi. 10.1093/rheumatology/keaa267
- By:
- Publication type:
- Article
An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databases.
- Published in:
- Rheumatology, 2020, v. 59, n. 8, p. 1842, doi. 10.1093/rheumatology/kez542
- By:
- Publication type:
- Article
Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension.
- Published in:
- Rheumatology, 2020, v. 59, n. 2, p. 281, doi. 10.1093/rheumatology/kez279
- By:
- Publication type:
- Article
Assessing joint inflammation—a way forward for SLE trials?
- Published in:
- 2019
- By:
- Publication type:
- Editorial
The relationship between remission and health-related quality of life in a cohort of SLE patients.
- Published in:
- Rheumatology, 2019, v. 58, n. 4, p. 628, doi. 10.1093/rheumatology/key349
- By:
- Publication type:
- Article
Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials.
- Published in:
- Rheumatology, 2017, v. 56, n. 4, p. 541, doi. 10.1093/rheumatology/kew370
- By:
- Publication type:
- Article
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aat3356
- By:
- Publication type:
- Article
Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02794-x
- By:
- Publication type:
- Article
The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02724-x
- By:
- Publication type:
- Article
Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis—a spin-off study of the NORD-STAR randomized clinical trial.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02556-1
- By:
- Publication type:
- Article
Long-Term Dietary Changes after Diagnosis of Rheumatoid Arthritis in Swedish Women: Data from a Population-Based Cohort.
- Published in:
- International Journal of Rheumatology, 2018, p. 1, doi. 10.1155/2018/9152480
- By:
- Publication type:
- Article
Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00902
- By:
- Publication type:
- Article
A PHASE 3, RANDOMIZED CONTROLLED TRIAL COMPARING UPADACITINIB MONOTHERAPY TO MTX MONOTHERAPY IN MTX-NAIVE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS.
- Published in:
- Acta Reumatológica Portuguesa, 2019, p. 27
- By:
- Publication type:
- Article
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients.
- Published in:
- BMC Immunology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2172-14-34
- By:
- Publication type:
- Article
Deucravacitinib: An Oral, Selective, Allosteric Tyrosine kinase 2 Inhibitor for Active Systemic Lupus Erythematosus.
- Published in:
- touchREVIEWS in RMD, 2022, v. 1, n. 2, p. 40, doi. 10.17925/RMD.2022.1.2.40
- By:
- Publication type:
- Article
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 3, p. 363, doi. 10.1002/art.42730
- By:
- Publication type:
- Article
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 2, p. 242, doi. 10.1002/art.42391
- By:
- Publication type:
- Article
What Does It Mean to Be a British Isles Lupus Assessment Group–Based Composite Lupus Assessment Responder? Post Hoc Analysis of Two Phase III Trials.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 11, p. 2059, doi. 10.1002/art.41778
- By:
- Publication type:
- Article
Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 6, p. 826, doi. 10.1002/art.40448
- By:
- Publication type:
- Article
A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 10, p. 1937, doi. 10.1002/art.40196
- By:
- Publication type:
- Article
Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 9, p. 1751, doi. 10.1002/art.40176
- By:
- Publication type:
- Article
A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 5, p. 953, doi. 10.1002/art.40019
- By:
- Publication type:
- Article
Editorial: Who Gets Lupus? Clues to a Tantalizing Syndrome.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 3, p. 483, doi. 10.1002/art.40005
- By:
- Publication type:
- Article
Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 9, p. 2184, doi. 10.1002/art.39682
- By:
- Publication type:
- Article
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 9, p. 2174, doi. 10.1002/art.39722
- By:
- Publication type:
- Article
VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 1, p. 46, doi. 10.1002/art.39473
- By:
- Publication type:
- Article
Brief Report: Enhancement of Patient Recruitment in Rheumatoid Arthritis Clinical Trials Using a Multi-Biomarker Disease Activity Score as an Inclusion Criterion.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 11, p. 2855, doi. 10.1002/art.39274
- By:
- Publication type:
- Article